Master Alliance Provisions Guide (MAPGuide)

Novavax – US Army Agreement for Research & Development of COVID-19 Vaccine

  • Term & termination | Term of agreement

Base Agreement Article II.  Term

Base Agreement Section 2.01   The Term of this Agreement

The period of performance for this Agreement is from the effective date, which is the date of last signature, to April 7, 2036. If at any time funds expended exceed the amount obligated on a Project Agreement prior to the expiration of the term, the Parties have no obligation to continue performance and may elect to cease their efforts at that point. Provisions of this Agreement, which, by their express terms or by necessary implication, apply for periods of time other than specified in Article II herein, shall be given effect, notwithstanding this Article.